54 phenotypes from 4 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Ccr5tm1Blck/Ccr5tm1Blck B6.129P2-Ccr5tm1Blck	abnormal cellular extravasation	J:104744
	abnormal leukocyte adhesion	J:104744
	abnormal response to cardiac infarction	J:104744
	increased length of allograft survival	J:105072
Ccr5tm1Brv/Ccr5tm1Brv either: (involves: 129S1/Sv * ICR) or (involves: 129S1/Sv * 129X1/SvJ * ICR)	abnormal cytokine secretion	J:46941
	decreased interleukin-1 beta secretion	J:46941
	decreased interleukin-6 secretion	J:46941
	decreased susceptibility to endotoxin shock	J:46941
	increased IgG1 level	J:46941
	increased interferon-gamma secretion	J:46941
	increased interleukin-4 secretion	J:46941
	increased susceptibility to bacterial infection	J:46941
	increased susceptibility to type IV hypersensitivity reaction	J:46941
Ccr5tm1Kuz/Ccr5+ involves: 129P2/OlaHsd	normal reproductive system phenotype	J:119074
Ccr5tm1Kuz/Ccr5tm1Kuz B6.129P2-Ccr5tm1Kuz	abnormal conditioned taste aversion behavior	J:102583
	normal behavior/neurological phenotype	J:84037
	bronchiolitis	J:162707
	corneal vascularization	J:118018
	increased alcohol consumption	J:102583
	increased fluid intake	J:102583
	increased susceptibility to Coronaviridae infection	J:162707
	normal mortality/aging	J:84037
	normal nervous system phenotype	J:84037
Ccr5tm1Kuz/Ccr5tm1Kuz B6.129P2-Ccr5tm1Kuz/J	decreased skeletal muscle glycogen level	J:264446
	impaired exercise endurance	J:264446
Ccr5tm1Kuz/Ccr5tm1Kuz involves: 129P2/OlaHsd	abnormal cardiovascular system physiology	J:227458
	abnormal heart size	J:227458
	decreased inflammatory response	J:227458
	decreased right ventricle systolic pressure	J:227458
	decreased susceptibility to injury	J:227458
Ccr5tm1Kuz/Ccr5tm1Kuz involves: 129P2/OlaHsd * C57BL/6	abnormal astrocyte physiology	J:153059
	abnormal CD4-positive, alpha beta T cell morphology	J:110814
	abnormal CD8-positive, alpha beta T cell morphology	J:110814
	abnormal cytokine level	J:110814
	abnormal glial cell physiology	J:153059
	abnormal hepatocyte physiology	J:100869
	abnormal Ito cell morphology	J:152548
	abnormal Kupffer cell morphology	J:152548
	abnormal locomotor behavior	J:110814
	abnormal long-term spatial reference memory	J:153059
	abnormal nervous system physiology	J:132342
	abnormal NK T cell physiology	J:100869
	abnormal spatial learning	J:153059
	decreased microglial cell activation	J:153059
	decreased NK cell number	J:135308
	decreased susceptibility to induced colitis	J:110814
	decreased susceptibility to Retroviridae infection	J:132342
	impaired macrophage chemotaxis	J:64293, J:84243, J:153059
	increased NK T cell number	J:110814
	increased susceptibility to fungal infection	J:64293
	liver failure	J:100869
Ccr5tm1Kuz/Ccr5tm1Kuz Tg(CAG-EGFP)1Osb/? involves: 129P2/OlaHsd * C3H * C57BL/6	decreased metastatic potential	J:97833
Ccr5tm1Sush/Ccr5tm1Sush B6.129P2-Ccr5tm1Sush	abnormal leukocyte physiology	J:94937
	decreased T cell proliferation	J:94937